Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Enamel hydroxyapatite mineral matrix is the hardest substance in the human body and serves as the primary structural component of tooth enamel (StatPearls, 2023). It is composed of crystalline calcium phosphate, specifically hydroxyapatite [Ca10(PO4)6(OH)2], arranged in a complex hierarchical structure of rods and inter-rod substance (PubChem CID 14781). The biological function of this matrix is to provide a durable, wear-resistant surface for chewing while protecting the underlying dentin and dental pulp from chemical, thermal, and bacterial insults (NIH, 2022). In the context of disease, the dissolution of this mineral matrix by organic acids produced by plaque bacteria leads to dental caries, while exposure to dietary acids causes dental erosion (StatPearls, 2023). Therapeutic agents like fluoride target this matrix by promoting the formation of fluorapatite, which has a lower solubility product and greater resistance to acid-induced demineralization (Journal of Dental Research, 2018). Additionally, biomimetic materials such as nano-hydroxyapatite are used to directly remineralize and repair the enamel surface by filling microporosities and restoring mineral density (Journal of Nanobiotechnology, 2019).
Fluoride ions substitute for hydroxyl groups in the hydroxyapatite lattice to form fluorapatite, which is more resistant to acid dissolution; additionally, remineralizing agents provide a source of calcium and phosphate to restore the mineral matrix (NIH, 2022; Journal of Dental Research, 2018).
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Enamel hydroxyapatite mineral matrix (HAP) (HAP).